Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline Performance Share Plan (PSP) notified the Company and the under-mentioned persons on 29 April 2013 of an increase in their interests in Ordinary Shares.
The following shares were released and were sold to meet tax liabilities as a result of the reinvestment of dividends paid on PSP awards which vested on 26 April 2013.
|
Ordinary shares released |
Number of Ordinary Shares sold to meet tax liabilities |
Mr R Connor |
11 |
6 |
Mr P Thomson |
9 |
5 |
Dr P Vallance |
297 |
140 |
Ms E Walmsley |
381 |
180 |
Mr C Weber |
48 |
0 |
Mrs V Whyte |
9 |
5 |
The Company and PDMRs were advised of these transactions on 29 April 2013.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
29 April 2013